Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
review article or handbook
Title:
Teratology study in rats, Stoddard solvent
Author:
API
Year:
1983
Bibliographic source:
Final report (Litton Bionetics Inc. Project No. 20698-2). Washington, DC, American Petroleum Institute (Microfiche FYI-AX-0183-0232).

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
Principles of method if other than guideline:
A Prenatal Development Toxicity Study equivalent or similar to OECD TG 414 was conducted using groups of 26 or 27 Sprague-Dawley female rats. Female rats were exposed by inhalation to white spirit (Stoddard solvent; boiling range, 157° to 204° C; 43% normal/branched aliphatics, 33% cyclic aliphatics, 24% aromatics) at concentrations of 0, 600, or 2400 mg/m3 (0, 100, and 400 ppm, respectively) for 6 hours per day on days 6 to 15 of gestation.
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Stoddard solvent
EC Number:
232-489-3
EC Name:
Stoddard solvent
Cas Number:
8052-41-3
Molecular formula:
C10H22
IUPAC Name:
stoddard solvent
Test material form:
liquid
Specific details on test material used for the study:
Stoddard solvent; boiling range, 157° to 204° C; 43% normal/branched aliphatics, 33% cyclic aliphatics, 24% aromatics)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories, Portage, MI
- Age at study initiation: 71 days
- Weight at study initiation: 261-264 g
- Housing: Individually housed in suspended stainless-steel cages with wire mesh floors and fronts- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 38-74
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
inhalation
Type of inhalation exposure (if applicable):
whole body
Vehicle:
air
Details on mating procedure:
Impregnation procedure:
cohoused- If cohoused:
- M/F ratio per cage: 1:1
- Length of cohabitation: nightly
- Verification of same strain and source of both sexes: yes
- Proof of pregnancy: vaginal plug and/or sperm in vaginal smear referred to as day 0 of pregnancy
Duration of treatment / exposure:
days 6 to 15 of gestation
Frequency of treatment:
once daily
Duration of test:
up to day 3 post partum
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/m³ air
Dose / conc.:
600 mg/m³ air
Remarks:
100 ppm
Dose / conc.:
2 400 mg/m³ air
Remarks:
400 ppm
No. of animals per sex per dose:
26 and 27 animals per group
Control animals:
yes, concurrent vehicle
Details on study design:
A Prenatal Development Toxicity Study equivalent or similar to OECD TG 414 was conducted using groups of 26 or 27 Sprague-Dawley female rats. Female rats were exposed by inhalation to white spirit (Stoddard solvent; boiling range, 157° to 204° C; 43% normal/branched aliphatics, 33% cyclic aliphatics, 24% aromatics) at concentrations of 0, 600, or 2400 mg/m3 (0, 100, and 400 ppm, respectively) for 6 hours per day on days 6 to 15 of gestation.

Examinations

Statistics:
2x2 Coningency tables; Chi Square testcorrected for discontinuity using Yates correction; 2x2 tables,
Fisher 's exact Probability test, ANOVA, Kruskal-Wallis H test, Student's t-test
Indices:
Reproductive Index; Gestation Index; Viability Index

Results and discussion

Results: maternal animals

General toxicity (maternal animals)

Clinical signs:
effects observed, non-treatment-related
Mortality:
no mortality observed
Details on results:
No maternal toxicity or differences in litter size or average fetal weight were seen between the groups. There were no statistical differences for skeletal variations between the control group and the 100 ppm or the 400 ppm exposed group. The study director noted that pups in one litter in the 100 ppm group one litter in 400 ppm exposed groups had at least one unusual skeletal finding. The unusual variations were reduced ossification in various bones of the pups. The pups from these two litters had a significant reduced mean body weight when compared to control and to the mean of the treatment group:
Control mean body weight: 3.6 g;
100 ppm mean body weight: 3.7g, 100 ppm litter with unusual findings: 1.4g;
400 ppm mean body weight: 3.7g, 400 ppm litter with unusual findings: 2.0g.
The study concluded that the effects were considered expressions of retarded growth rather than malformations. Based on this information, the developmental NOAEC = 2400 mg/m3 or 400 ppm, the highest concentration tested.

Effect levels (maternal animals)

Dose descriptor:
NOAEC
Effect level:
2 400 mg/m³ air
Based on:
test mat.
Basis for effect level:
body weight and weight gain
clinical signs
Remarks on result:
other:
Remarks:
based on expressions of retarded growth and not malformations

Maternal abnormalities

Abnormalities:
not specified

Results (fetuses)

Fetal body weight changes:
effects observed, treatment-related
Details on embryotoxic / teratogenic effects:
No maternal toxicity or differences in litter size or average fetal weight were seen between the groups. There were no statistical differences for skeletal variations between the control group and the 100 ppm or the 400 ppm exposed group. The study director noted that pups in one litter in the 100 ppm group one litter in 400 ppm exposed groups had at least one unusual skeletal finding. The unusual variations were reduced ossification in various bones of the pups. The pups from these two litters had a significant reduced mean body weight when compared to control and to the mean of the treatment group:
Control mean body weight: 3.6 g;
100 ppm mean body weight: 3.7g, 100 ppm litter with unusual findings: 1.4g;
400 ppm mean body weight: 3.7g, 400 ppm litter with unusual findings: 2.0g.
The study concluded that the effects were considered expressions of retarded growth rather than malformations. Based on this information, the developmental NOAEC = 2400 mg/m3 or 400 ppm, the highest concentration tested.

Effect levels (fetuses)

Dose descriptor:
NOAEC
Effect level:
2 400 mg/m³ air
Based on:
test mat.
Sex:
male/female
Basis for effect level:
fetal/pup body weight changes
Remarks on result:
other:
Remarks:
based on significant reduced mean body weight when compared to control and to the mean of the treatment group

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

A Prenatal Development Toxicity Study equivalent or similar to OECD TG 414 was conducted using groups of 26 or 27 Sprague-Dawley female rats. Female rats were exposed by inhalation to white spirit (Stoddard solvent; boiling range, 157° to 204° C; 43% normal/branched aliphatics, 33% cyclic aliphatics, 24% aromatics) at concentrations of 0, 600, or 2400 mg/m3(0, 100, and 400 ppm, respectively) for 6 hours per day on days 6 to 15 of gestation. No maternal toxicity or differences in litter size or average fetal weight were seen between the groups. There were no statistical differences for skeletal variations between the control group and the 100 ppm or the 400 ppm exposed group. The study director noted that pups in one litter in the 100 ppm group one litter in 400 ppm exposed groups had at least one unusual skeletal finding. The unusual variations were reduced ossification in various bones of the pups. The pups from these two litters had a significant reduced mean body weight when compared to control and to the mean of the treatment group:

Control mean body weight: 3.6 g;

100 ppm mean body weight: 3.7g, 100 ppm litter with unusual findings: 1.4g;

400 ppm mean body weight: 3.7g, 400 ppm litter with unusual findings: 2.0g.

The study concluded that the effects were considered expressions of retarded growth rather than malformations. Based on this information, the developmental NOAEC = 2400 mg/m3 or 400 ppm, the highest concentration tested.

Applicant's summary and conclusion

Conclusions:
The study concluded that the effects were considered expressions of retarded growth rather than malformations. Based on this information, the developmental NOAEC = 2400 mg/m3 or 400 ppm, the highest concentration tested.
Executive summary:

A Prenatal Development Toxicity Study equivalent or similar to OECD TG 414 was conducted using groups of 26 or 27 Sprague-Dawley female rats. Female rats were exposed by inhalation to white spirit (Stoddard solvent; boiling range, 157° to 204° C; 43% normal/branched aliphatics, 33% cyclic aliphatics, 24% aromatics) at concentrations of 0, 600, or 2400 mg/m3(0, 100, and 400 ppm, respectively) for 6 hours per day on days 6 to 15 of gestation. No maternal toxicity or differences in litter size or average fetal weight were seen between the groups. There were no statistical differences for skeletal variations between the control group and the 100 ppm or the 400 ppm exposed group. The study director noted that pups in one litter in the 100 ppm group one litter in 400 ppm exposed groups had at least one unusual skeletal finding. The unusual variations were reduced ossification in various bones of the pups. The pups from these two litters had a significant reduced mean body weight when compared to control and to the mean of the treatment group:

Control mean body weight: 3.6 g;

100 ppm mean body weight: 3.7g, 100 ppm litter with unusual findings: 1.4g;

400 ppm mean body weight: 3.7g, 400 ppm litter with unusual findings: 2.0g.

The study concluded that the effects were considered expressions of retarded growth rather than malformations. Based on this information, the developmental NOAEC = 2400 mg/m3 or 400 ppm, the highest concentration tested.